A bug only a scientist could love -- UM professor unlocking secrets of STD by University of Montana--Missoula. Office of University Relations
University of Montana 
ScholarWorks at University of Montana 
University of Montana News Releases, 1928, 
1956-present University Relations 
2-26-1998 
A bug only a scientist could love -- UM professor unlocking 
secrets of STD 
University of Montana--Missoula. Office of University Relations 
Follow this and additional works at: https://scholarworks.umt.edu/newsreleases 
Let us know how access to this document benefits you. 
Recommended Citation 
University of Montana--Missoula. Office of University Relations, "A bug only a scientist could love -- UM 
professor unlocking secrets of STD" (1998). University of Montana News Releases, 1928, 1956-present. 
15200. 
https://scholarworks.umt.edu/newsreleases/15200 
This News Article is brought to you for free and open access by the University Relations at ScholarWorks at 
University of Montana. It has been accepted for inclusion in University of Montana News Releases, 1928, 
1956-present by an authorized administrator of ScholarWorks at University of Montana. For more information, 
please contact scholarworks@mso.umt.edu. 
v Montana
%  The University of
UNIVERSITY RELATIONS • MISSOULA, MT 59812 • 406-243-2522 • FAX: 406-243-4520
This release is available electronically on INN (News Net.)
Feb. 26, 1998
Contact: Ralph Judd, UM biology professor, (406) 243-2347.
A BUG ONLY A SCIENTIST COULD LOVE -  
UM PROFESSOR UNLOCKING SECRETS OF STD
MISSOULA—
Ralph Judd, a microbiology professor and researcher at The University of Montana- 
Missoula, admits people usually take a step back when they learn what he studies.
He even gets similar reactions from his family at times. Once as a graduate student, he left 
his wife, Vicki, waiting in the car while he hurried into a lab to get some fresh bacteria cultures.
When he returned, Mrs. Judd said, “You know, not every wife would wait around while her 
husband goes to get gonorrhea.”
That’s been a running joke in the Judd household since he started studying gonorrhea, a 
sexually transmitted disease characterized by painful urination and discharge of pus, in the early 
1970s.
Though the disease is seldom life threatening, having gonorrhea is an uncomfortable 
experience that can cause sterility and painful joints. Among females the S TD also can cause severe 
abdominal pain, cramping, a life-threatening tubal pregnancy or -  in rare cases -  a dangerous 




Judd said research at his UM laboratory has three major goals -- to study the physiology of 
the gonorrhea bacterium, design a simple diagnostic test to detect the organism and develop a 
vaccine to prevent infections.
Gonorrhea is a huge problem around the world, especially in Third World countries. Judd 
said the problem is less pronounced in the United States, but there are still up to 500,000 infections 
reported in this country every year. And the organism is sneaky, since 20 percent of infected men 
and most infected women don’t display symptoms but can still pass on the disease.
Despite these grim facts, Judd said he has always been fascinated by gonococcus, the 
bacterium that causes gonorrhea. Gonococci are extremely versatile organisms seemingly designed 
to baffle the human immune system.
“I love the little things," Judd said. “We are their universe, since the gonococcus exists only 
in humans. Anything we learn about them tells us about ourselves.”
He said our immune systems recognize molecules on the surfaces of invading organisms. But 
a gonococcus has the ability to spontaneously change its surface markers into almost infinite 
varieties. By the time the immune system has discovered the invader and started to fight back, Judd 
said, “the gonococcus has already changed its coat. The organism really knows how to fool us.”
Gonococci seem to sucker immune systems with dominant molecules on their surfaces that 
they keep changing. However, Judd and his staff have discovered less-prominent surface molecules - 
- like Outer Membrane Protein 85 (Omp85) — that seem to stay fairly constant.
“If we make antibodies to these minor molecules, would it kill the bacteria?” he asked.
“This might lead us to a vaccine.”
Judd’s lab contributed to the discovery of the efflux pump system, a drug-resistance
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mechanism used by gonorrhea bacteria, along with Dr. W.M. Shafer of Emory University in 
Atlanta. The lab also is studying what role the newly discovered protein Omp85 plays with the 
disease.
“Right now it looks like Omp85 may not be essential to the life of the organism,” he said, 
“but even if it isn’t, there are other proteins we are interested in pursuing.”
Under normal circumstances, gonorrhea can be cured readily with antibiotics once a patient 
begins displaying symptoms. A gonorrhea infection also may run its course in several uncomfortable 
weeks or months -- fraught with possible side effects — if treatment is not sought.
The current test to diagnose gonorrhea involves cultivating the bacteria and can be fairly 
expensive. A swab is taken of the potentially infected area, and then a culture is grown over a three- 
day period. Judd said the current test is only 80 percent effective.
If Judd can discover a molecule on gonococcus that is always expressed, he envisions a 
cheaper diagnostic test -- similar to a home pregnancy test -- that would become widely used by 
STD clinics and perhaps be sold over the counter. If a urine sample or swab contains gonorrhea, 
antibodies on a test strip would bind to gonococcal proteins, causing a color change.
“Right now we are working on a test where, if gonorrhea is present, the test strip turns 
purple,” he said. “If it turns yellow, you have chlamydia (another STD), and if it turns green, you 
have both. You don’t want green.”
Judd admitted they need some research breakthroughs before a home gonorrhea test or 
vaccine to prevent infection is available.
He said the problem with producing a vaccine is that it’s difficult to stimulate immune 
responses on mucosal surfaces, which are located in areas such as the eyes, nose, genitals or
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intestines. But once an immune response is triggered, immunity is conveyed to all mucosal surfaces 
in the body.
Judd said microbiologist Scott Manning, a UM adjunct assistant research professor, is 
working on vaccination strategies designed to stimulate mucosal immunity. Manning is studying the 
possibility of a gonorrhea vaccine taken orally that would trigger immunity in the intestines and thus 
in the genitalia.
“This research might also help with AIDS and infections like genital warts,” Judd said.
Most of Judd’s research funding comes from the National Institutes of Health, but he said it’s 
getting increasingly difficult to garner funding for gonorrhea research in this era of AIDS.
Judd emphasizes that he is only one of several researchers in his laboratory. He said 
undergraduates, graduate students and UM faculty all work together as a team trying to unlock the 
secrets of gonococcus. He said one of the most rewarding aspects of working at UM is the 
opportunity to teach and work with students. He teaches freshman, junior, senior and graduate-level 
courses.
Eight people work in Judd’s lab, and even though they work closely with the bacteria, they 
have never had a laboratory infection of gonorrhea.
“It’s funny. I work with the gonococcus all the time, but I’ve never actually seen an 
infection,” Judd said. “But that’s OK.”
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